Previous results also indicate that PI3K/Akt pathway inhibition enhances the sensitivity of NSCLC cells to ionizing radiation, suggesting that PI3K/Akt inhibitors may be a strategy to reduce NSCLC radioresistance [50]. Here, AKT1 is linked to non-small cell lung carcinoma.